Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

ReNeuron completes £9.5mm IPO

Executive Summary

Stem-cell technologies company ReNeuron Group PLC (therapeutics for CNS disorders) has completed its initial public offering of about 38mm common shares priced at £0.25 each, raising £9.5mm ($16.7mm)--£500k less than it was seeking when it filed last month. The shares will trade on London's AIM.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies